Skip to content

3D Imaging of Hard and Soft Tissue in Orthognathic Surgery

An Analysis of the Clinical Applicability of a Three-Dimensional Imaging Platform Used to Register the Influence of Orthognathic Surgery on Facial Hard and Soft Tissue in Patients With Congenital Maxillofacial Deformities.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00285714
Enrollment
450
Registered
2006-02-02
Start date
2006-02-28
Completion date
2010-12-31
Last updated
2007-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Lip, Cleft Palate, Craniofacial Abnormalities, Maxillofacial Abnormalities

Keywords

3D computer assisted imaging, maxillofacial surgery, cephalometry, normative value

Brief summary

The primary objective of this clinical trial is to assess the influence of orthognathic surgery on facial soft tissue, such as changes (volume, linear, angular) of facial hard and soft tissue, in three dimensions, so enabling the setup of 3D normative value tables.

Interventions

PROCEDURE3D stereophotogrammetric imaging
PROCEDURE3D CT-imaging with cone-beam CT

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Dysgnathic deformity * Caucasian * \> 15 years * No history of orthognathic surgery * Informed Consent

Exclusion criteria

* \< 15 years * History of Orthognathic surgery * Not Caucasian

Design outcomes

Primary

MeasureTime frame
All changes (volumetric, linear or angular) of facial hard and soft tissue caused by orthognathic surgery at 1 months, 6 months, 12 months and 24 months.

Secondary

MeasureTime frame
All postoperative changes in functionality at 1 year
patients' satisfaction of facial proportions at 1 year
surgeons' satisfaction of the 3D planning platform at 1 month

Countries

Netherlands

Contacts

Primary ContactJoanneke Plooij, MD
j.plooij@mka.umcn.nl+31-24-3619464
Backup ContactThomas Maal, MsC
t.maal@mka.umcn.nl+31-24-3614845

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026